Valganciclovir Hydrochloride 450mg Tablets from Japan
These are oral tablets containing 450mg of valganciclovir hydrochloride, an antiviral medication used to treat cytomegalovirus (CMV) infections in immunocompromised patients. Classified under HTS 3004.90.92.05 as an anti-infective antiviral medicament put up in measured doses for retail sale, consisting of valganciclovir salt in unmixed form.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Obtain FDA approval and ensure compliance with drug import regulations including NDC labeling
• Provide certificates of analysis confirming valganciclovir hydrochloride content and purity
• Avoid misclassification as unmixed bulk API which falls outside retail dose requirements